TODAY'S HEADLINES

Diabetes drug to make billions

Novo Nordisk's new insulin drug is officially on the market and the company stands to sell billions of dollars worth of the long-acting insulin. Read more

Opdivo use expands to yet another cancer

After approving Opdivo to treat advanced squamous non-small cell lung cancer and metastatic renal cell carcinoma last year, FDA recently approved Opdivo + Yervoy for metastatic melanoma. Read more

CONTINUING PHARMACY EDUCATION

LAW: Primer on biosimilar agents

This month's CE activity is open for pharmacists and pharmacy technicians, "LAW: Primer on biosimilar agents." Pharmacists and pharmacy technicians can earn up to 2 hours of CPE law credit for completing this knowledge-based activity from the University of Connecticut School of Pharmacy and Drug Topics. More

EDITOR'S PICK

Mount Sinai diabetes program uses smart data

The smart data analytics platform, which captures information from a variety of sources, including connected glucose meters, personal devices and electronic health records, is being expanded to help diabetic patients in addition to Mount Sinai employees. Details

February 5, 2016

Related Articles

FDA expands use for lung cancer drug

New insulin drug to enter crowded market